AI Startup Collate Raises $95 Million To Automate Life Sciences Paperwork
forbes.com Jun 4, 2026

AI Startup Collate Raises $95 Million To Automate Life Sciences Paperwork

AI-summarised brief · reviewed before publication

AI startup Collate has raised $95 million in funding, led by Redpoint Ventures, to automate life sciences paperwork. The company, founded by Surbhi Sarna, has developed AI tools to streamline regulatory filings, clinical trials, and product development for life sciences companies. Collate has signed over 50 customers, including major pharmaceutical companies and publicly traded biotech firms, since its launch in 2025. The funding brings Collate's total valuation to nearly $1 billion and highlights the growing demand for AI solutions in the life sciences industry.

💡 Why It Matters

  • · The life sciences industry's reliance on manual paperwork creates a massive opportunity for AI to disrupt and improve efficiency.
  • · By automating documentation, Collate is poised to capitalize on this trend, potentially surpassing the success of AI-powered legal solutions.